Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Alexander Mark Schobel currently holds 984,476 shares of Aquestive Therapeutics, Inc. (AQST), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Alexander Mark Schobel has been a net seller of AQST stock. They have purchased $79.4K and sold $1.6M worth of shares.
Alexander Mark Schobel's most recent insider trade was on Mar 15, 2024, when they sold 50,000 shares at $6.00 per share.
Alexander Mark Schobel serves as Executive at Aquestive Therapeutics, Inc. (AQST). They have executed 51 insider transactions totaling $1.7M over their tenure at the company.
Alexander Mark Schobel holds the position of Executive at Aquestive Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Alexander Mark Schobel has shown a selling trading pattern, with $79.4K in total purchases and $1.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Alexander Mark Schobel was on Mar 15, 2024, when they sold $300.0K worth of AQST shares. This transaction involved 50,000 shares at $6.00 per share.
Alexander Mark Schobel currently owns 984,476 shares of Aquestive Therapeutics, Inc. (AQST), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Alexander Mark Schobel's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Alexander Mark Schobel has 51 Form 4 filings on record as an insider at Aquestive Therapeutics, Inc..
Set alerts for Alexander Mark Schobel and 40,000+ other insiders.